Yang, Shenmiao http://orcid.org/0000-0001-7261-8449
Kay, Neil E. http://orcid.org/0000-0002-5951-5055
Shi, Min http://orcid.org/0000-0002-5741-4293
Ossenkoppele, Gert
Walter, Roland B. http://orcid.org/0000-0002-9268-3341
Gale, Robert Peter http://orcid.org/0000-0002-9156-1676
Article History
Received: 26 August 2021
Revised: 3 September 2021
Accepted: 7 September 2021
First Online: 27 September 2021
Competing interests
: NEK is on the Advisory Board for Abbvie, Astra Zeneca, Behring, Cytomx Therapy, Dava Oncology, Janssen, Juno Therapeutics, Oncotracker, Pharmacyclics and Targeted Oncology. DSMC (Data Safety Monitoring Committee) for Agios Pharm, Astra Zeneca, BMS –Celgene, Cytomx Therapeutics, Janssen, Morpho-sys, Rigel. He received research funding from Abbvie, Acerta Pharma, Bristol Meyer Squib, Celgene, Genentech, MEI Pharma, Pharmacyclics, Sunesis, TG Therapeutics and Tolero Pharmaceuticals. RPG is a consultant to BeiGene Ltd., Fusion Pharma LLC, LaJolla NanoMedical Inc., Mingsight Parmaceuticals Inc., CStone Pharmaceuticals, NexImmune Inc. and Prolacta Bioscience; advisor to Antengene Biotech LLC, Medical Director, FFF Enterprises Inc.; Partner, AZCA Inc.; Board of Directors, Russian Foundation for Cancer Research Support; and Scientific Advisory Board: StemRad Ltd.
Free to read: This content has been made available to all.